> Skip repeated content
photo of Allan Gibofsky, MD, JD, MACR, FACP, FCLM

Allan Gibofsky, MD, JD, MACR, FACP, FCLM

Rheumatology

About Dr. Gibofsky

Dr. Allan Gibofsky has conducted extensive research on rheumatic fever and rheumatoid arthritis. He is a Professor of Medicine at Weill Cornell Medical College and an Attending Rheumatologist at Hospital for Special Surgery, where he is co-Director of the Clinic for Inflammatory Arthritis and Biologic Therapy.

Departments

Specialized Centers

Inflammatory Arthritis Center

Patient Stories

Insurance

Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.

Credentials

Appointments

Attending Physician, Hospital for Special Surgery
Professor of Medicine, Weill Cornell Medical College

Certification

Rheumatology
Internal Medicine

Awards

Master, The American College of Rheumatology, 2014
Castle Connolly Top Doctors in New York Metro Area, 2005-2022
New York Magazine Top Doctors, 2021, 2022

Education

MD, Weill Cornell Medical School, New York

JD, Fordham University School of Law

Residency

The New York Hospital, New York

Fellowship

Hospital for Special Surgery - Rockefeller University

State Licensure

Languages

English

Publications by Dr. Gibofsky

Patient Education

Blog Posts

Research

Industry Relationships

Industry Relationships

One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.

As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.

Below are the healthcare industry relationships reported by Dr. Gibofsky as of November 25, 2021.

  • AbbVie Inc. - Advisory Board; Consultant; Honoraria; Ownership Interest; Speakers' Bureau
  • American College of Rheumatology - Committee Member
  • Amgen -Consultant, Ownership Interest - Speakers’ Bureau
  • Biosplice Therapeutics - Consultant
  • Horizon Therapeutics - Consultant
  • Johnson & Johnson- Ownership Interest
  • Lilly USA, LLC - Consultant
  • Novartis - Speakers' Bureau
  • Pfizer, Inc. - Author; Advisory Board; Consultant; Ownership Interest; Speakers' Bureau
  • The Rheumatology Education Group - Speakers' Bureau
  • Up-to-Date- Author

By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.

Patients should feel free to ask their HSS physicians questions about these relationships.

Dr. Gibofsky in the News